NO975718D0 - Behandling av insulinresistens - Google Patents

Behandling av insulinresistens

Info

Publication number
NO975718D0
NO975718D0 NO975718A NO975718A NO975718D0 NO 975718 D0 NO975718 D0 NO 975718D0 NO 975718 A NO975718 A NO 975718A NO 975718 A NO975718 A NO 975718A NO 975718 D0 NO975718 D0 NO 975718D0
Authority
NO
Norway
Prior art keywords
treatment
insulin resistance
insulin
resistance
Prior art date
Application number
NO975718A
Other languages
English (en)
Other versions
NO975718L (no
Inventor
Jerrold M Olefsky
Tahir S Pillay
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO975718D0 publication Critical patent/NO975718D0/no
Publication of NO975718L publication Critical patent/NO975718L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO975718A 1995-06-07 1997-12-05 Behandling av insulinresistens NO975718L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/485,393 US6511811B1 (en) 1995-06-07 1995-06-07 Protein kinase C antagonist related to insulin receptor
PCT/US1996/009662 WO1996040894A1 (en) 1995-06-07 1996-06-07 Treatment of insulin resistance

Publications (2)

Publication Number Publication Date
NO975718D0 true NO975718D0 (no) 1997-12-05
NO975718L NO975718L (no) 1998-02-04

Family

ID=23927981

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975718A NO975718L (no) 1995-06-07 1997-12-05 Behandling av insulinresistens

Country Status (7)

Country Link
US (2) US6511811B1 (no)
EP (1) EP0832204A4 (no)
JP (1) JP2001520508A (no)
AU (1) AU720920B2 (no)
CA (1) CA2223891A1 (no)
NO (1) NO975718L (no)
WO (1) WO1996040894A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3473999A (en) * 1998-04-03 1999-10-25 Chiron Corporation Injectable igf-formulations containing succinate as buffering agent
AU783594B2 (en) * 1999-04-15 2005-11-10 South Eastern Sydney Area Health Service Method of prophylaxis and treatment of diabetes
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
TW200423677A (en) 2003-04-01 2004-11-01 Matsushita Electric Ind Co Ltd Communication apparatus and authentication apparatus
US7727752B2 (en) * 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
EP1508806A1 (en) * 2003-08-16 2005-02-23 Aventis Pharma Deutschland GmbH A method for the identification of IRS protein kinase inhibitors or agonists
US7803571B2 (en) * 2003-08-16 2010-09-28 Sanfoi-Aventis Deutschland GmbH Method for identifying IRS inhibitors or agonists
JP2007505315A (ja) * 2003-09-12 2007-03-08 インヴィトロジェン コーポレーション 多重結合および活性アッセイ
JP2005239629A (ja) * 2004-02-26 2005-09-08 Tendou Seiyaku Kk インスリン受容体のリン酸化阻害剤
AU2006263332B2 (en) * 2005-06-29 2012-02-23 Hadasit Medical Research Services & Development Ltd. Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
JP5151155B2 (ja) * 2007-01-19 2013-02-27 富士通株式会社 マイクロインジェクション用キャピラリ針の製造方法および製造装置
US20120208750A1 (en) * 2009-09-29 2012-08-16 Joslin Diabetes Center, Inc. Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
US8785648B1 (en) 2010-08-10 2014-07-22 The Regents Of The University Of California PKC-epsilon inhibitors
EP3180003B1 (en) 2014-07-01 2022-01-12 The Regents of the University of California Pkc-epsilon inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
EP0445227A4 (en) 1988-11-23 1991-12-27 The Regents Of The University Of California Position-specific insertion vectors and method of using same
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors

Also Published As

Publication number Publication date
JP2001520508A (ja) 2001-10-30
US20030211540A1 (en) 2003-11-13
EP0832204A4 (en) 2001-12-19
EP0832204A1 (en) 1998-04-01
NO975718L (no) 1998-02-04
WO1996040894A1 (en) 1996-12-19
AU720920B2 (en) 2000-06-15
US6511811B1 (en) 2003-01-28
CA2223891A1 (en) 1996-12-19
AU6264796A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
DE69631514D1 (de) Steuerbarer katheter
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DE69626168T2 (de) Infusionskatheter
LV11615A (lv) Amidi ar arstnieciskam ipasibam
DE69630305D1 (de) Elektrodenkatheter
BR9602635A (pt) Conjunto de cateter
BR9602637A (pt) Cateter
DE69510024D1 (de) Spritze
FI964874A (fi) Vihannesten käsittely
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
DK0747069T3 (da) Implanterbar medicinsk anordning
DE69427970D1 (de) Medikament gegen atopische krankheiten
NO20001479L (no) Behandling av atferdsforstyrrelse
NO975718D0 (no) Behandling av insulinresistens
EG21712A (en) Treatment of insulin resistance
FI973216A0 (fi) Diabeettisen neuropatian hoito
FI931234A0 (fi) Foerfarande foer oevervakning av en patients tillstaond
BR9507086A (pt) Tratamento de nefroterapia diabética com valsartan
DE69619051D1 (de) Behandlung von Füllstoffen mit Oxasilacycloalkanen
FI950389A0 (fi) Ny medicinsk anvaendning av hemiprodukter
NO982562D0 (no) Sammensetning for behandling av smerte
KR970000449U (ko) 일회용 주사기
NO20000274D0 (no) Behandling av fluider
SE9504669D0 (sv) Positionerbar behandlingskateter
UA915S (uk) Канюля медична